-
2
-
-
0026498986
-
Naltrexone and coping skills therapy for alcohol dependence: A controlled study
-
O'Malley SS, Jaffe AJ, Chang G, Schottenfeld RS, Meyer RE, Rounsaville B. Naltrexone and coping skills therapy for alcohol dependence: a controlled study. Arch Gen Psychiatry. 1992;49:881-887.
-
(1992)
Arch Gen Psychiatry
, vol.49
, pp. 881-887
-
-
O'Malley, S.S.1
Jaffe, A.J.2
Chang, G.3
Schottenfeld, R.S.4
Meyer, R.E.5
Rounsaville, B.6
-
3
-
-
21844499396
-
Naltrexone in the treatment of alcohol dependence; a combined analysis of two trials
-
O'Malley SS, Croop RS, Wroblewski JW, Labriola DF, Volpicelli JR. Naltrexone in the treatment of alcohol dependence; a combined analysis of two trials. Psychiatric Annals. 1995;25:681-688.
-
(1995)
Psychiatric Annals
, vol.25
, pp. 681-688
-
-
O'Malley, S.S.1
Croop, R.S.2
Wroblewski, J.W.3
Labriola, D.F.4
Volpicelli, J.R.5
-
8
-
-
0027688912
-
Prevalence of comorbid alcohol disorder and consumption in medically ill and depressed patients
-
Sherbourne CD, Hays RD, Wells KB, Rogers W, Burnam MA. Prevalence of comorbid alcohol disorder and consumption in medically ill and depressed patients. Arch Fam Med. 1993;2:1142-1150.
-
(1993)
Arch Fam Med
, vol.2
, pp. 1142-1150
-
-
Sherbourne, C.D.1
Hays, R.D.2
Wells, K.B.3
Rogers, W.4
Burnam, M.A.5
-
9
-
-
0027665871
-
Alcohol and depression
-
Madden JS. Alcohol and depression. Br J Hosp Med. 1993;50:261-263.
-
(1993)
Br J Hosp Med
, vol.50
, pp. 261-263
-
-
Madden, J.S.1
-
10
-
-
0022195837
-
Effects of long-term therapy with naltrexone on body weight in obesity
-
Atkinson RL, Berke LK, Drake CR, Bibbs ML, Williams FL, Kaiser DL Effects of long-term therapy with naltrexone on body weight in obesity. Clin Pharmacol Ther. 1985;38:419-422.
-
(1985)
Clin Pharmacol Ther
, vol.38
, pp. 419-422
-
-
Atkinson, R.L.1
Berke, L.K.2
Drake, C.R.3
Bibbs, M.L.4
Williams, F.L.5
Kaiser, D.L.6
-
11
-
-
0022377228
-
A controlled trial of naltrexone in obese humans
-
Malcolm RJ, O'Neill PM, Seizer JD, Riddle FE, Currey HS. A controlled trial of naltrexone in obese humans. Int J Obes. 1985;9:347-353.
-
(1985)
Int J Obes.
, vol.9
, pp. 347-353
-
-
Malcolm, R.J.1
O'Neill, P.M.2
Seizer, J.D.3
Riddle, F.E.4
Currey, H.S.5
-
12
-
-
0023087016
-
High-dose naltrexone therapy and dietary counseling for obesity
-
Mitchell JE, Morley JE, Levine AS, Hatsukami D, Gannon M, Pfohl D. High-dose naltrexone therapy and dietary counseling for obesity. Biol Psychiatry. 1987;22:35-42.
-
(1987)
Biol Psychiatry
, vol.22
, pp. 35-42
-
-
Mitchell, J.E.1
Morley, J.E.2
Levine, A.S.3
Hatsukami, D.4
Gannon, M.5
Pfohl, D.6
-
13
-
-
0022930515
-
Naltrexone hydrochloride (Trexan): A review of serum transaminase elevations at high dosage
-
Pfohl DN, Allen JI, Atkinson RL, Knopman DS, Malcolm RJ, Mitchell JE, Morley JE. Naltrexone hydrochloride (Trexan): a review of serum transaminase elevations at high dosage. NIDA Res Monogr. 1986;67:66-72.
-
(1986)
NIDA Res Monogr
, vol.67
, pp. 66-72
-
-
Pfohl, D.N.1
Allen, J.I.2
Atkinson, R.L.3
Knopman, D.S.4
Malcolm, R.J.5
Mitchell, J.E.6
Morley, J.E.7
-
14
-
-
0028092159
-
Lack of hepatotoxicity with naltrexone treatment
-
Sax DS, Kornetsky C, Kim A. Lack of hepatotoxicity with naltrexone treatment. J Clin Pharmacol. 1994;34:898-901.
-
(1994)
J Clin Pharmacol
, vol.34
, pp. 898-901
-
-
Sax, D.S.1
Kornetsky, C.2
Kim, A.3
|